http://www.cn360cn.com/f5210891.htm Web5 de ago. de 2024 · Healx has developed a range of technologies which utilise artificial intelligence (AI) to identify and progress new therapies for rare diseases that don’t currently have an approved treatment. Its AI drug discovery platform, Healnet, integrates data from sources such as biomedical research and articles, to form a detailed rare disease …
UK-QSAR Autumn 2024 UK QSAR and Cheminformatics Group
WebI am a doctor in Cellular and Molecular Biology and Biochemistry. I work as Senior Rare Disease Scientist at Healx, an AI-powered drug discovery/repurposing company in Cambridge, UK. In my role, I help to evaluate the potential of rare disease candidates to be included in the company's portfolio, based on reviews of disease biology, unmet needs, … Web20 de oct. de 2024 · Healx. British startup Healx has secured FDA approval for a phase 2a clinical trial of an AI-discovered compound that could help manage the symptoms of the … lampen gamma hang
Healx raises $56M Series B to use AI to find treatments for rare ...
Web20 de oct. de 2024 · Cambridge, England-based startup Healx will begin a year-long trial with around 70 patients to test if HLX-0201, a drug compound that was originally developed as an anti-inflammatory treatment,... Web19 de jul. de 2024 · Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Our AI drug discovery platform leverages public and proprietary ... Read more Biotechnology Headquarters Cambridge, England, United Kingdom, Contact Unlock contact Linkedin … WebH, that aims to be the true artificial intelligence. One technology that has realized a greater level of versatility is Hitachi AI Technology/H (hereafter "H"), which was announced by Hitachi in 2015. H responds to a wide range of applications, automatically generating a large number of hypotheses -- over one million -- from the data itself and ... lampen galerie